Zhang Dengyong

12/2022- till now, MD Anderson cancer center, Visiting scholar 09/2021- till now, Anhui medical university, surgery, doctor’s degree 09/2012 – 06/2015,Bengbu Medical College, surgery, Master's degree 09/2007 –06/2012, Bengbu Medical College,medicine,Bachelor's degree Work Experience – please list all work experience 07/2016-today, First Afiliated Hospital of Bengbu Medical College No 287,Changhuai Road，longzihu District，Bengbu，Anhui province，China,233000 attending doctor. 06/2015-07/2016, Lu'an traditional Chinese Medicine Hospital, No. 76 Renmin road, Jin’an district, Lu'an, Anhui province,Resident. Awards and Group Memberships – if any 1.Act as reviewer of magazines such as Oncology Reports, Molecular Medicine Reports, Oncology Letters, Experimental and Therapeutic Medicine, etc. 2.Natural science fund of Anhui Province, 2018.12-2020.12, (1808085QH288), R1； 3.Anhui Provincial Natural Science Foundation, 2020.6-2023.6, (2008085MH256）, R2 Publications – please list all publications, if any 1.Wang D, Sun W, Zhou S, Liu Z, Lu Z, Zhang DY. Application of mesohepatectomy with caudate lobectomy for the treatment of type III–IV hilar cholangiocarcinoma: a single-center retrospective study. Eur J Med Res 28, 234 (2023). https://doi.org/10.1186/s40001-023-01209-0 2.Zhang DY, Liu S, Wu Q, Ma Y, Zhou S, Liu Z, Sun W and Lu Z.Prognostic model for hepatocellular carcinoma based on anoikisrelated genes: immune landscape analysis and prediction of drug sensitivity. Front Med. 2023, 10:1232814. 10:1232814. doi: 10.3389/fmed.2023.1232814. 3.Zhang DY, Zhao G, Sun W, Wang D, Zhou S, Liu Z, Lu Z. Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma. Sci Rep. 2023, 13（1）, 3177. 4.Y Ma, Wl Sun, SS Ma, GR Zhao, Z Liu, Z Lu, Zhang DY . LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients. BMC Bioinformatics. 2023, 24（1）, 54.  5.Zhang DY, Ma Y, Sun W, Wang N, Liu Z, Lu Z. Primary suture for patients of bile duct stones after laparoscopic biliary tract exploration: a retrospective cohort study. Updates Surg. 2023;10.1007/s13304-023-01451-5.  6.Zhang DY, Qi FY, Sun W, Zhao GR , Wang DD, Zhou S, Liu Z and Lu Z. Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort. Eur J Med Res. 2022, 27:214-221. 7.Lei J, Ma S, Sun W, Wang D, Lu Z, Zhang DY. High expression of H2A histone family member Y promotes the proliferation and autophagy of hepatocellular carcinoma cells. Bioengineered. 2022;13(4):10654-10664. 8.Zhang DY, Lu Z. A Circular Intrahepatic Portal Vein. J Coll Physicians Surg Pak. 2021;31(3):365-366. 9.Zhang DY, Lu Z. Pancreatic Abscess Misdiagnosed and Treated as Pancreatic Cancer. J Coll Physicians Surg Pak. 2021;31(4):472-474.  10.Zhang DY, Ma SS, Sun WL, Lv XCH, Lu Z. KIF4A as a novel prognostic biomarker in cholangiocarcinoma. Medicine (Baltimore). 2021;100(21):e26130 11.Zhang DY, Lei JS, Sun WL, Wang DD, Lu Z. Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma. Chin Med J 2020;133:1798–1804. 12.Zhang DY, Liu Z, Lu Z, Sun WL, Ma X, Zhang P, Wu BQ, Cui PY. Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma. Onco Targets Ther. 2018;11:7133-7142. 13.Zhang DY, Sun WL, Ma X, et al. Up-regulated FSTL5 inhibits invasion of hepatocellular carcinoma through the Wnt/β-catenin/YAP pathway. Int J Clin Exp Pathol. 2017;10(10):10325-10333.  14.Zhang DY, Ma X, Sun W, Cui P, Lu Z，Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma. Int J Clin Exp Pathol,2015,1;8(3):3386-94. 15.Zhang DY, Lu Z, Ma X, et al. Multiple Hemolymphangioma of the Visceral Organs: A Case Report and Review of the Literature. Medicine (Baltimore). 2015;94(27):e1126.  16.Lei J, Zhang DY, Yao C, Ding S, Lu Z. Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis. Cancer Control. 2020;27(1):1073274820977114.  17.Ma S, Li C, Ma Y, Wang X, Zhang DY, Lu Z. A retrospective study on the clinical and pathological features of hepatic sarcomatoid carcinoma: Fourteen cases of a rare tumor. Medicine (Baltimore). 2022;101(31):e30005. Travel History – please list all countries you have visited Adelaide, Australia (May8-12, 2017), RACS ASC 2017 (Royal Australasian College of Surgeons Annual Scientific Congress).